Wilson Sonsini Goodrich & Rosati advised Dren Bio on the transaction. Dren Bio, Inc., a privately held, clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune,...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented InduPro in the transaction. InduPro, Inc., a biotechnology company announced an $85 million Series A financing co-led by The Column...
You must be a Standard 1 Year member to access this content.
Paul Weiss Rifkind Wharton & Garrison is advising IBM on the transaction, and Wilson Sonsini Goodrich & Rosati is advising HashiCorp. IBM (NYSE: IBM) and HashiCorp Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Rambus in the transaction. Rambus Inc. (NASDAQ: RMBS) announced that it initiated an accelerated share repurchase program with Royal Bank of Canada...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Neurona Therapeutics on the transaction. Neurona Therapeutics announced it closed a $120 million financing co-led by Viking Global Investors and Cormorant...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented both Valor Capital and Hack VC in the transaction. Nonco, an institutional digital asset brokerage firm, announced it has completed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Valor Capital on the transaction. Nexu announced it has raised $20 million in a Series B funding. The round was led...
You must be a Standard 1 Year member to access this content.
